| Harold Lynn Rodgers Jr, MD | |
|
1125 Raintree Cir, Suite 100, Allen, TX 75013-4900 | |
| (972) 727-9995 | |
| (972) 727-8350 |
| Full Name | Harold Lynn Rodgers Jr |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 42 Years |
| Location | 1125 Raintree Cir, Allen, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225037559 | NPI | - | NPPES |
| P00913329 | Other | TX | MEDICARE RAILROAD - EFFECT 02/01/2011 |
| HH011A | Other | BCBS | |
| TXB117535 | Other | TX | MEDICARE PART B - EFFECT. 02/01/2011 |
| 8CR168 | Other | TX | BC/BS TX - EFFECT. 02/01/2011 |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | G6001 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Legacy Healthcare Services Inc | 2163339722 | 2654 |
News Archive
Cell Therapeutics, Inc. today announced that a comprehensive article summarizing preclinical and clinical data for pacritinib, an oral JAK2/FLT3 inhibitor, authored by Srdan Verstovsek, M.D., Ph.D., et al., was published in the journal Drugs of the Future 2013.
Nurses working in hospitals around the world are reporting they are burned out and dissatisfied with their jobs, reported researchers at the University of Pennsylvania School of Nursing's Center for Health Outcomes and Policy Research in a study of 100,000 nurses in nine countries.
CTS Corporation today announced fourth quarter 2009 revenues of $133.9 million, 6% higher than third quarter 2009 revenues of $126.6 million. Fourth quarter 2009 net earnings were $4.1 million, or $0.12 per diluted share, including a discrete tax valuation allowance charge of $2.5 million (or $0.07 per diluted share). Excluding this charge, fourth quarter non-GAAP adjusted net earnings were $6.6 million, or $0.19 per diluted share, compared to third quarter 2009 net earnings of $4.5 million, or $0.13 per diluted share.
Accretive Health, Inc., a healthcare technology and services company, and Cancer Clinics of Excellence (CCE), a national network of practice-owned, physician-driven community-based oncology practices, announced today that they have partnered to develop a novel, end-to-end oncology care management offering designed to enable healthcare providers to improve the efficacy and quality of cancer care while simultaneously improving the affordability of the healthcare system.
› Verified 9 days ago
| Entity Name | Medhealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912957200 PECOS PAC ID: 9931001567 Enrollment ID: O20040123000832 |
News Archive
Cell Therapeutics, Inc. today announced that a comprehensive article summarizing preclinical and clinical data for pacritinib, an oral JAK2/FLT3 inhibitor, authored by Srdan Verstovsek, M.D., Ph.D., et al., was published in the journal Drugs of the Future 2013.
Nurses working in hospitals around the world are reporting they are burned out and dissatisfied with their jobs, reported researchers at the University of Pennsylvania School of Nursing's Center for Health Outcomes and Policy Research in a study of 100,000 nurses in nine countries.
CTS Corporation today announced fourth quarter 2009 revenues of $133.9 million, 6% higher than third quarter 2009 revenues of $126.6 million. Fourth quarter 2009 net earnings were $4.1 million, or $0.12 per diluted share, including a discrete tax valuation allowance charge of $2.5 million (or $0.07 per diluted share). Excluding this charge, fourth quarter non-GAAP adjusted net earnings were $6.6 million, or $0.19 per diluted share, compared to third quarter 2009 net earnings of $4.5 million, or $0.13 per diluted share.
Accretive Health, Inc., a healthcare technology and services company, and Cancer Clinics of Excellence (CCE), a national network of practice-owned, physician-driven community-based oncology practices, announced today that they have partnered to develop a novel, end-to-end oncology care management offering designed to enable healthcare providers to improve the efficacy and quality of cancer care while simultaneously improving the affordability of the healthcare system.
› Verified 9 days ago
| Entity Name | Total Joint Cin Of North Texas Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023523669 PECOS PAC ID: 6103188578 Enrollment ID: O20180322002039 |
News Archive
Cell Therapeutics, Inc. today announced that a comprehensive article summarizing preclinical and clinical data for pacritinib, an oral JAK2/FLT3 inhibitor, authored by Srdan Verstovsek, M.D., Ph.D., et al., was published in the journal Drugs of the Future 2013.
Nurses working in hospitals around the world are reporting they are burned out and dissatisfied with their jobs, reported researchers at the University of Pennsylvania School of Nursing's Center for Health Outcomes and Policy Research in a study of 100,000 nurses in nine countries.
CTS Corporation today announced fourth quarter 2009 revenues of $133.9 million, 6% higher than third quarter 2009 revenues of $126.6 million. Fourth quarter 2009 net earnings were $4.1 million, or $0.12 per diluted share, including a discrete tax valuation allowance charge of $2.5 million (or $0.07 per diluted share). Excluding this charge, fourth quarter non-GAAP adjusted net earnings were $6.6 million, or $0.19 per diluted share, compared to third quarter 2009 net earnings of $4.5 million, or $0.13 per diluted share.
Accretive Health, Inc., a healthcare technology and services company, and Cancer Clinics of Excellence (CCE), a national network of practice-owned, physician-driven community-based oncology practices, announced today that they have partnered to develop a novel, end-to-end oncology care management offering designed to enable healthcare providers to improve the efficacy and quality of cancer care while simultaneously improving the affordability of the healthcare system.
› Verified 9 days ago
| Entity Name | Stx Care Of Tx Ii, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700348299 PECOS PAC ID: 1557794153 Enrollment ID: O20191212002797 |
News Archive
Cell Therapeutics, Inc. today announced that a comprehensive article summarizing preclinical and clinical data for pacritinib, an oral JAK2/FLT3 inhibitor, authored by Srdan Verstovsek, M.D., Ph.D., et al., was published in the journal Drugs of the Future 2013.
Nurses working in hospitals around the world are reporting they are burned out and dissatisfied with their jobs, reported researchers at the University of Pennsylvania School of Nursing's Center for Health Outcomes and Policy Research in a study of 100,000 nurses in nine countries.
CTS Corporation today announced fourth quarter 2009 revenues of $133.9 million, 6% higher than third quarter 2009 revenues of $126.6 million. Fourth quarter 2009 net earnings were $4.1 million, or $0.12 per diluted share, including a discrete tax valuation allowance charge of $2.5 million (or $0.07 per diluted share). Excluding this charge, fourth quarter non-GAAP adjusted net earnings were $6.6 million, or $0.19 per diluted share, compared to third quarter 2009 net earnings of $4.5 million, or $0.13 per diluted share.
Accretive Health, Inc., a healthcare technology and services company, and Cancer Clinics of Excellence (CCE), a national network of practice-owned, physician-driven community-based oncology practices, announced today that they have partnered to develop a novel, end-to-end oncology care management offering designed to enable healthcare providers to improve the efficacy and quality of cancer care while simultaneously improving the affordability of the healthcare system.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Harold Lynn Rodgers Jr, MD 1125 Raintree Cir, Suite 100, Allen, TX 75013-4900 Ph: (972) 727-9995 | Harold Lynn Rodgers Jr, MD 1125 Raintree Cir, Suite 100, Allen, TX 75013-4900 Ph: (972) 727-9995 |
News Archive
Cell Therapeutics, Inc. today announced that a comprehensive article summarizing preclinical and clinical data for pacritinib, an oral JAK2/FLT3 inhibitor, authored by Srdan Verstovsek, M.D., Ph.D., et al., was published in the journal Drugs of the Future 2013.
Nurses working in hospitals around the world are reporting they are burned out and dissatisfied with their jobs, reported researchers at the University of Pennsylvania School of Nursing's Center for Health Outcomes and Policy Research in a study of 100,000 nurses in nine countries.
CTS Corporation today announced fourth quarter 2009 revenues of $133.9 million, 6% higher than third quarter 2009 revenues of $126.6 million. Fourth quarter 2009 net earnings were $4.1 million, or $0.12 per diluted share, including a discrete tax valuation allowance charge of $2.5 million (or $0.07 per diluted share). Excluding this charge, fourth quarter non-GAAP adjusted net earnings were $6.6 million, or $0.19 per diluted share, compared to third quarter 2009 net earnings of $4.5 million, or $0.13 per diluted share.
Accretive Health, Inc., a healthcare technology and services company, and Cancer Clinics of Excellence (CCE), a national network of practice-owned, physician-driven community-based oncology practices, announced today that they have partnered to develop a novel, end-to-end oncology care management offering designed to enable healthcare providers to improve the efficacy and quality of cancer care while simultaneously improving the affordability of the healthcare system.
› Verified 9 days ago
Dr. Adam Christopher Hines, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 963 State Highway 121 Ste 1150, Allen, TX 75013 Phone: 469-322-1400 Fax: 469-322-1401 | |
Michael D Adams, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1125 Raintree Cir, Suite 100, Allen, TX 75013 Phone: 972-727-9995 Fax: 972-727-8350 | |
Sarang N Desai, DO Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1125 Raintree Cir Ste 100, Allen, TX 75013 Phone: 972-727-9995 Fax: 972-727-8350 | |
Andrew Parker, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1110 Raintree Circle, Suite 100, Allen, TX 75013 Phone: 214-383-9356 | |
Steven B Morgan, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1125 Raintree Cir, Suite 100, Allen, TX 75013 Phone: 972-727-9995 Fax: 972-727-8350 | |
Dr. Christopher Odom, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 963 State Highway 121 Ste 1150, Allen, TX 75013 Phone: 469-322-1400 Fax: 469-322-1401 |